Helen Reeves

Citada per

	Totes	Des de 2019
Citacions	29897	16138
Índex h	50	40
Índex i10	90	75

3200

1600

800

2400

200320042005200620072008200920102011201220132014201520162017201820192020202120222023202499 124 140 221 217 296 664 850 931 1101 1192 1225 1375 1470 1606 1747 1977 2440 2977 2991 3126 2612

Accés públic

Mostra-ho tot

73 articles

7 articles

disponibles

no disponibles

Es basa en els requisits de les agències que proporcionen el finançament

Coautors

C DayNewcastle UniversityCorreu electrònic verificat a ncl.ac.uk
Alastair BurtUniversity of AdelaideCorreu electrònic verificat a adelaide.edu.au
Scott L. FriedmanProfessor of MedicineCorreu electrònic verificat a mssm.edu
Goutham Narla - Chief, Division of Ge...University of MichiganCorreu electrònic verificat a med.umich.edu
Stephen L. Chan 陳林醫生教授Professor, Department of Clinical Oncology, The Chinese University of Hong KongCorreu electrònic verificat a cuhk.edu.hk
Luca MieleFondazione Pol. Univ. A. Gemelli IRCCS, Università Cattolica Sacro Cuore. RomaCorreu electrònic verificat a policlinicogemelli.it
DINA TINIAKOSNational and Kapodistrian University of Athens, Newcastle UniversityCorreu electrònic verificat a med.uoa.gr
Derek MannProfessor of Hepatology, Newcastle UniversityCorreu electrònic verificat a newcastle.ac.uk
Ann DalyProfessor of Pharmacogenetics, Newcastle UniversityCorreu electrònic verificat a ncl.ac.uk
Luca ValentiAssociate Professor of Internal Medicine, Università degli Studi di Milano, Fondazione Ca' GrandaCorreu electrònic verificat a unimi.it
James O'BeirneSunshine Coast University Hospital, Sunshine Coast Hospital and Health ServiceCorreu electrònic verificat a health.qld.gov.au
David JamiesonNewcastle UniversityCorreu electrònic verificat a ncl.ac.uk
Loranne AgiusNewcastle UniversityCorreu electrònic verificat a ncl.ac.uk
Augusto VillanuevaIcahn School of Medicine at Mount SinaiCorreu electrònic verificat a mssm.edu
Andrew M.-L. ChanThe Chinese University of Hong KongCorreu electrònic verificat a cuhk.edu.hk
Frank TackeProfessor of Medicine, Charité University Medicine BerlinCorreu electrònic verificat a charite.de
Karine ClementProfesseur de nutrition, Sorbonne UniversityCorreu electrònic verificat a inserm.fr
Guruprasad AithalUniversity of Nottingham and NIHR Nottingham Biomedical Research CentreCorreu electrònic verificat a nottingham.ac.uk
Amalia GastaldelliInstitute of Clinical Physiology, CNRCorreu electrònic verificat a cnr.it
Karen E. HeathClinical molecular geneticist & Senior researcher, INGEMM, IdiPAZ, Hospital Universitario la PazCorreu electrònic verificat a salud.madrid.org

Segueix

Helen Reeves

Newcastle University

Correu electrònic verificat a newcastle.ac.uk - Pàgina d'inici

Hepatology Liver Cancer Fatty Liver Disease Personalised Medicine Biomarkers


Títol Ordena per cites Ordena per any Ordena per títol	Citada per Citada per	Any
Sorafenib in advanced hepatocellular carcinoma JM Llovet, S Ricci, V Mazzaferro, P Hilgard, E Gane, JF Blanc, ... New England journal of medicine 359 (4), 378-390, 2008	15412	2008
Assessment of liver function in patients with hepatocellular carcinoma: a new evidence-based approach—the ALBI grade PJ Johnson, S Berhane, C Kagebayashi, S Satomura, M Teng, ... Journal of Clinical Oncology 33 (6), 550-558, 2015	2412	2015
From NASH to HCC: current concepts and future challenges QM Anstee, HL Reeves, E Kotsiliti, O Govaere, M Heikenwalder Nature reviews Gastroenterology & hepatology 16 (7), 411-428, 2019	1240	2019
Activation of hepatic stellate cells—a key issue in liver fibrosis HL Reeves, SL Friedman Front Biosci 7 (4), 808-826, 2002	735	2002
TM6SF2 rs58542926 influences hepatic fibrosis progression in patients with non-alcoholic fatty liver disease YL Liu, HL Reeves, AD Burt, D Tiniakos, S McPherson, JBS Leathart, ... Nature communications 5 (1), 4309, 2014	728	2014
Hepatocellular cancer: the impact of obesity, type 2 diabetes and a multidisciplinary team J Dyson, B Jaques, D Chattopadyhay, R Lochan, J Graham, D Das, ... Journal of hepatology 60 (1), 110-117, 2014	705	2014
KLF6, a candidate tumor suppressor gene mutated in prostate cancer G Narla, KE Heath, HL Reeves, D Li, LE Giono, AC Kimmelman, ... Science 294 (5551), 2563-2566, 2001	615	2001
Carriage of the PNPLA3 rs738409 C> G polymorphism confers an increased risk of non-alcoholic fatty liver disease associated hepatocellular carcinoma YL Liu, GL Patman, JBS Leathart, AC Piguet, AD Burt, JF Dufour, CP Day, ... Journal of hepatology 61 (1), 75-81, 2014	593	2014
A positive feedback loop between RIP 3 and JNK controls non‐alcoholic steatohepatitis J Gautheron, M Vucur, F Reisinger, DV Cardenas, C Roderburg, C Koppe, ... EMBO molecular medicine 6 (8), 1062-1074, 2014	319	2014
The detection of hepatocellular carcinoma using a prospectively developed and validated model based on serological biomarkers PJ Johnson, SJ Pirrie, TF Cox, S Berhane, M Teng, D Palmer, J Morse, ... Cancer Epidemiology, Biomarkers & Prevention 23 (1), 144-153, 2014	318	2014
Role of the GALAD and BALAD-2 serologic models in diagnosis of hepatocellular carcinoma and prediction of survival in patients S Berhane, H Toyoda, T Tada, T Kumada, C Kagebayashi, S Satomura, ... Clinical Gastroenterology and Hepatology 14 (6), 875-886. e6, 2016	302	2016
Non-invasive stratification of hepatocellular carcinoma risk in non-alcoholic fatty liver using polygenic risk scores C Bianco, O Jamialahmadi, S Pelusi, G Baselli, P Dongiovanni, I Zanoni, ... Journal of hepatology 74 (4), 775-782, 2021	274	2021
MBOAT7 rs641738 variant and hepatocellular carcinoma in non-cirrhotic individuals B Donati, P Dongiovanni, S Romeo, M Meroni, M McCain, L Miele, S Petta, ... Scientific reports 7 (1), 4492, 2017	269	2017
A germline DNA polymorphism enhances alternative splicing of the KLF6 tumor suppressor gene and is associated with increased prostate cancer risk G Narla, A DiFeo, HL Reeves, DJ Schaid, J Hirshfeld, E Hod, A Katz, ... Cancer research 65 (4), 1213-1222, 2005	269	2005
Molecular pathogenesis and systemic therapies for hepatocellular carcinoma JM Llovet, R Pinyol, RK Kelley, A El-Khoueiry, HL Reeves, XW Wang, ... Nature cancer 3 (4), 386-401, 2022	256	2022
NASH in lean individuals R Younes, E Bugianesi Seminars in liver disease 39 (01), 086-095, 2019	254	2019
Kruppel-like factor 6 (KLF6) is a tumor-suppressor gene frequently inactivated in colorectal cancer HL Reeves, G Narla, O Ogunbiyi, AI Haq, A Katz, S Benzeno, E Hod, ... Gastroenterology 126 (4), 1090-1103, 2004	229	2004
The Kruppel-like factor 6 genotype is associated with fibrosis in nonalcoholic fatty liver disease L Miele, G Beale, G Patman, V Nobili, J Leathart, A Grieco, M Abate, ... Gastroenterology 135 (1), 282-291. e1, 2008	225	2008
Targeted inhibition of the KLF6 splice variant, KLF6 SV1, suppresses prostate cancer cell growth and spread G Narla, A DiFeo, S Yao, A Banno, E Hod, HL Reeves, RF Qiao, ... Cancer Research 65 (13), 5761-5768, 2005	205	2005
Cyclin-dependent kinase inhibition by the KLF6 tumor suppressor protein through interaction with cyclin D1 S Benzeno, G Narla, J Allina, GZ Cheng, HL Reeves, MS Banck, JA Odin, ... Cancer research 64 (11), 3885-3891, 2004	205	2004

En aquests moments el sistema no pot dur a terme l'operació. Torneu-ho a provar més tard.

Articles 1–20

Cites per any

Cites duplicades

Cites combinades

Addició de coautorsCoautors

Segueix

Citada per

Coautors